Biography and Research Information
OverviewAI-generated summary
Kerri Hill's research focuses on the study and application of stem cell transplantation, particularly in the context of multiple myeloma. Her work investigates the feasibility of outpatient stem cell transplantation and identifies risk factors associated with hospital admission. Hill has published on salvage autologous stem cell transplantation for patients with daratumumab-refractory multiple myeloma. She has collaborated with researchers at the University of Arkansas for Medical Sciences, including Guido Tricot, Clyde Bailey, Sravani Gundarlapalli, and Sharmilan Thanendrarajan, with whom she shares multiple publications. Her scholarship metrics include an h-index of 3, with a total of 5 publications and 37 citations.
Metrics
- h-index: 3
- Publications: 5
- Citations: 37
Selected Publications
-
Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission (2022)
-
Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma (2021)
-
Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM). (2021)
Collaboration Network
Top Collaborators
Lakshmi Yarlagadda
University of Arkansas for Medical Sciences (US)
3 shared publications
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
Sravani Gundarlapalli
University of Arkansas for Medical Sciences
3 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
Richa Parikh
University of Arkansas for Medical Sciences (US)
3 shared publications
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
Mathew Kottarathara
University of Arkansas for Medical Sciences (US)
3 shared publications
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
Yetunde Ogunsesan
University of Arkansas for Medical Sciences (US)
3 shared publications
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
Shadiqul Hoque
University of Arkansas for Medical Sciences (US)
3 shared publications
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
Angel Mitma
University of Arkansas for Medical Sciences (US)
3 shared publications
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
Clyde Bailey
University of Arkansas for Medical Sciences
3 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
Sharmilan Thanendrarajan
University of Arkansas for Medical Sciences
3 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
Meera Mohan
Medical College of Wisconsin (US)
3 shared publications
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
Maurizio Zangari
University of Arkansas for Medical Sciences
3 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
Frits van Rhee
University of Arkansas for Medical Sciences
3 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
Guido Tricot
University of Arkansas for Medical Sciences
3 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
Carolina Schinke
University of Arkansas for Medical Sciences
3 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
Monica Graziutti
University of Arkansas for Medical Sciences
2 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
Similar Researchers
Based on overlapping research topics
Bart Barlogie
University of Arkansas for Medical Sciences
Hematopoietic Stem Cell Transplantation
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
B Barlogie
University of Arkansas for Medical Sciences
Hematopoietic Stem Cell Transplantation
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Munawar Hussain .
University of Arkansas for Medical Sciences
Hematopoietic Stem Cell Transplantation
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Monica Graziutti
University of Arkansas for Medical Sciences
Hematopoietic Stem Cell Transplantation
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Frits Vanrhee
University of Arkansas for Medical Sciences
Hematopoietic Stem Cell Transplantation
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Clyde Baily
University of Arkansas for Medical Sciences
Hematopoietic Stem Cell Transplantation
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology